These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15127593)

  • 1. [Research progress on regulation of class II MHC expression].
    Sun QH; Peng JP
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):25-9. PubMed ID: 15127593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of the Bare lymphocyte syndrome.
    Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
    Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bare lymphocyte syndrome and the regulation of MHC expression.
    Reith W; Mach B
    Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.
    Waldburger JM; Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Landmann S; Reith W
    Immunol Rev; 2000 Dec; 178():148-65. PubMed ID: 11213800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency.
    Villard J; Lisowska-Grospierre B; van den Elsen P; Fischer A; Reith W; Mach B
    N Engl J Med; 1997 Sep; 337(11):748-53. PubMed ID: 9287230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
    J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.
    Peijnenburg A; Van Eggermond MJ; Gobin SJ; Van den Berg R; Godthelp BC; Vossen JM; Van den Elsen PJ
    J Immunol; 1999 Jul; 163(2):794-801. PubMed ID: 10395672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes.
    Lochamy J; Rogers EM; Boss JM
    Mol Immunol; 2007 Feb; 44(5):837-47. PubMed ID: 16730065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
    Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
    Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I and II deficiencies.
    Hanna S; Etzioni A
    J Allergy Clin Immunol; 2014 Aug; 134(2):269-75. PubMed ID: 25001848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.